MAP2K3 and neoplasm: Interestingly, in such a context, targeting tumor-specific upstream signaling could also theoretically offer higher safety, because of the capability of parallel and compensatory signaling to buffer unwanted cytotoxic effects in healthy cells37: in this perspective, MKK3 inhibitors have recently been developed4,38.